Product Reports Resources Pricing Login Book a demo

Biotech & Life Sciences

Drug discovery, gene editing, synthetic biology

Companies inventing new medicines and biological technologies — gene therapies, mRNA platforms, synthetic biology, computational drug discovery. Long timelines, immense upside.

1.3 Quarterly report

Biotech & Life Sciences's latest quarter in venture capital

Venture capital raised by Biotech & Life Sciences companies worldwide each quarter since 2020, split by round size, with detail on the latest complete quarter.

Latest complete quarter

 

Loading VC raised by Biotech & Life Sciences companies…

3.1 Rounds & valuations

Largest Biotech & Life Sciences rounds & most valuable companies

A live treemap of $100M+ rounds — or switch the view to size companies by their latest valuation (EV). Filter by HQ region; drag the year slider to add earlier rounds.

Largest Biotech & Life Sciences rounds - Global 2026

Every $100M+ VC round classified as Biotech & Life Sciences in 2026, grouped by company HQ location.
- rounds · - raised
Location
Live from Dealroom API Open full VC dashboard

3.2 By destination

Where Biotech & Life Sciences capital lands

The same Biotech & Life Sciences VC, by destination — group by continent, country, city or sector, switch between amount raised and number of rounds, and read it as a ranked bar chart or a heat map over time. Live from the Dealroom API.

4.1 Sector comparison

How Biotech & Life Sciences stacks up

Compare Biotech & Life Sciences with the other simplified sectors — switch between combined EV, 5-year EV growth, and a growth × size view. Expand the table for every sector.

$3.5T
$1.9T
$1.7T
Biotech & Life Sciences
$1.1T
$920B

Combined enterprise value of each sector.

4.2 Market sentiment

What the market is saying about Biotech & Life Sciences

An AI-synthesized read of the highest-engagement posts about Biotech & Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

Biotech & Life Sciences has a deep pipeline of startups at every stage

By stage reached; about 1,262 new startups a year, 1,017 of them funded. Hover a stage for conversion rates.

  1. 7,942 Startups $100K–15M raised
    2,190 pre-seed · 2,749 seed · 3,003 Series A
  2. 3,912 Breakouts $15–100M raised
    2,111 Series B · 1,801 Series C
  3. 1,631 Scaleups $100M+ raised
    1,202 Mega · 429 Mega+
  4. 558 Unicorns valued at $1B+
    506 at $1–10B · 52 at $10–100B

Source: Dealroom.co, November 2026 · biotech & life sciences companies worldwide; bar heights on a log scale

VC investment

When the capital landed in Biotech & Life Sciences

VC investment into Biotech & Life Sciences companies over the last decade, broken down by round size, company location, sector and funding stage. Counts VC rounds into companies tagged or classified to Biotech & Life Sciences. Live from the Dealroom API.

Open the VC investment dashboard →

Enterprise value

Biotech & Life Sciences enterprise value

Combined enterprise value of VC-backed biotech & life sciences companies founded since 1990, at the end of each year.

Exits

Biotech & Life Sciences exits

Acquisitions, buyouts and listings of VC-backed biotech & life sciences companies. Value counts only the exits with a disclosed price.

Geographic concentration

Where Biotech & Life Sciences startups concentrate

Cities and countries ranked by Biotech & Life Sciences unicorns headquartered there, plus countries that over-index the global average (5× = 5× more represented than globally).

Get the full Biotech & Life Sciences sector on Dealroom

Live deal flow, founder pedigree, hiring signals and revenue trajectories — for every Biotech & Life Sciences startup.